is bpc 157 harmful Frontiers BPC-157 Explained: Potential Benefits, Risks,
Description
Cagrilintide had one of the lowest GI odds ratios among incretin-class compounds in a 2025 network meta-analysis, but combination GI burden has not been formally quantified
Typically $500 to $3,000+ depending on facility and insurance
Side effects are generally mild and may include slight soreness at the injection site or temporary warmth
This code applies when the injection specifically addresses the tendon structure rather than the subacromial bursa, which would require a different code
